DNA repair pathways and cisplatin resistance: an intimate relationship
Top Cited Papers
Open Access
- 1 January 2018
- Vol. 73 (Suppl 1) , e478s
Abstract
The main goal of chemotherapeutic drugs is to induce massive cell death in tumors. Cisplatin is an antitumor drug widely used to treat several types of cancer. Despite its remarkable efficiency, most tumors show intrinsic or acquired drug resistance. ...Keywords
This publication has 98 references indexed in Scilit:
- Structural basis for cisplatin DNA damage tolerance by human polymerase η during cancer chemotherapyNature Structural & Molecular Biology, 2012
- DNA interstrand crosslink repair and cancerNature Reviews Cancer, 2011
- Error-prone translesion synthesis mediates acquired chemoresistanceProceedings of the National Academy of Sciences, 2010
- Differential Roles for DNA Polymerases Eta, Zeta, and REV1 in Lesion Bypass of Intrastrand versus Interstrand DNA Cross-LinksMolecular and Cellular Biology, 2010
- DNA resection in eukaryotes: deciding how to fix the breakNature Structural & Molecular Biology, 2010
- Mechanisms of double-strand break repair in somatic mammalian cellsBiochemical Journal, 2009
- Two‐polymerase mechanisms dictate error‐free and error‐prone translesion DNA synthesis in mammalsThe EMBO Journal, 2009
- Prognostic significance of DNA repair proteins MLH1, MSH2 and MGMT expression in non‐small‐cell lung cancer and precursor lesionsHistopathology, 2008
- Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapyBritish Journal of Cancer, 2007
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003